|
🐬
|
Evidence of a Role for Monocytes in Dissemination and Brain Invasion by Cryptococcus neoformans
C. Charlier,
Kirsten Nielsen,
S. Daou,
M. Brigitte,
F. Chrétien,
F. Dromer
|
8 |
2008 |
8
🐬
|
|
🦁
|
Idiopathic thrombocytopenic purpura in elderly patients: a study of 47 cases from a single reference center.
S. Daou,
Laure Fédérici,
J. Zimmer,
F. Maloisel,
K. Serraj,
E. Andrès
|
5 |
2008 |
5
🦁
|
|
🦁
|
The potential role of cobalt ions released from metal prosthesis on the inhibition of Hv1 proton channels and the decrease in Staphyloccocus epidermidis killing by human neutrophils.
S. Daou,
Antoun El Chemaly,
P. Christofilopoulos,
L. Bernard,
P. Hoffmeyer,
N. Demaurex
|
5 |
2011 |
5
🦁
|
|
🐜
|
Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity
10 auth.
Y. Bouatou,
C. Samer,
K. Ing Lorenzini,
Y. Daali,
S. Daou,
M. Fathi,
...
M. Rebsamen,
J. Desmeules,
A. Calmy,
M. Escher
|
3 |
2014 |
3
🐜
|
|
🐜
|
Impact of Recommendation Updates in Well-Controlled Patients on Nonrecommended Antiretroviral Therapies: The Swiss HIV Cohort Study
11 auth.
N. Boillat-Blanco,
K. Darling,
P. Taffé,
R. Osih,
C. Strahm,
Maddalena Adami,
...
L. Elzi,
S. Daou,
J. Fehr,
G. Wandeler,
M. Cavassini
|
2 |
2013 |
2
🐜
|
|
🐜
|
PP134—Esomeprazole used as a booster in a HIV ultrarapid CYP2C19 metabolizer treated with voriconazole
10 auth.
Y. Bouatou,
C. Samer,
K. I. Lorenzini,
Y. Daali,
S. Daou,
M. Fathi,
...
M. Rebsamen,
J. Desmeules,
A. Calmy,
M. Escher
|
1 |
2013 |
1
🐜
|
|
🦁
|
Intracranial hypertension following highly active antiretroviral therapy interruption in an HIV-infected woman: case report and review of the literature.
S. Daou,
J. Ambrosioni,
D. Merkler,
A. Calmy
|
1 |
2013 |
1
🦁
|
|
🐬
|
Idiopathic thrombocytopenic purpura: preliminary results in patients aged >65 years.
E. Andrès,
S. Daou,
L. Federici,
J. Zimmer
|
0 |
2007 |
0
🐬
|
